Taiwan FDA registration 35377d1177603db53c3a192c4977635f
"Abe" human T-lymphotropic virus Western ink 2.4 test reagent
TW: "安倍"人類嗜T淋巴球病毒西方墨跡2.4檢驗試劑
Taiwan·Risk Class 3·MP BIOMEDICALS ASIA PACIFIC PTE. LTD.·Registered Mar 06, 2006 – Dec 07, 2028ActiveRegistration details
- Analysis ID
- 35377d1177603db53c3a192c4977635f
- Customs Code
- DHA00601608109
Company information
- Manufacturer
- MP BIOMEDICALS ASIA PACIFIC PTE. LTD.
- Manufacturer Country
- Singapore
- Authorized Representative
- SCN TRADING COMPANY LIMITED
Product details
- Intended Use
- Western ink spots are legally tested for human T-lymphotropic virus type 1 and type 2 antibodies in human serum or plasma, and are used for confirmation.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.4020 Analysis of specific tests
- Import Information
- import
Dates and status
- Registration Date
- Mar 06, 2006
- Expiry Date
- Dec 07, 2028
About this record
Access comprehensive regulatory information for "Abe" human T-lymphotropic virus Western ink 2.4 test reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 35377d1177603db53c3a192c4977635f and manufactured by MP BIOMEDICALS ASIA PACIFIC PTE. LTD.. The authorized representative in Taiwan is SCN TRADING COMPANY LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices